Events

The Cost and Value of Biomedical Innovation: Implications for Health Policy

USCThe Cost and Value of Biomedical Innovation: Implications for Health Policy

On Wednesday, October 1, the Engelberg Center for Health Care Reform and the USC Schaeffer Center for Health Policy and Economics will host a half-day forum to discuss the serious coverage challenges that accompany breakthrough treatments, such as the much-discussed new treatment for Hepatitis C, Sovaldi. Researchers will present economic modeling simulations that illustrate the value and long-term effects of such treatments; and explore potential policy solutions for financingĀ  biomedical innovations.

RNWHEN:
October 1, 2014
9:00 AM – 1:00 PM EDT

WHERE:
Falk Auditorium
1775 Massachusetts Ave., NW
Washington, DC

Additional Information